These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32468492)
1. GMP Tiered Cell Banking of Non-enzymatically Isolated Dermal Progenitor Fibroblasts for Allogenic Regenerative Medicine. Laurent A; Scaletta C; Michetti M; Hirt-Burri N; de Buys Roessingh AS; Raffoul W; Applegate LA Methods Mol Biol; 2021; 2286():25-48. PubMed ID: 32468492 [TBL] [Abstract][Full Text] [Related]
2. Progenitor Biological Bandages: An Authentic Swiss Tool for Safe Therapeutic Management of Burns, Ulcers, and Donor Site Grafts. Laurent A; Scaletta C; Michetti M; Hirt-Burri N; Flahaut M; Raffoul W; de Buys Roessingh AS; Applegate LA Methods Mol Biol; 2021; 2286():49-65. PubMed ID: 32572700 [TBL] [Abstract][Full Text] [Related]
3. Swiss Fetal Transplantation Program and Non-enzymatically Isolated Primary Progenitor Cell Types for Regenerative Medicine. Laurent A; Scaletta C; Hirt-Burri N; Raffoul W; de Buys Roessingh AS; Applegate LA Methods Mol Biol; 2021; 2286():1-24. PubMed ID: 32430595 [TBL] [Abstract][Full Text] [Related]
4. Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds. Laurent A; Lin P; Scaletta C; Hirt-Burri N; Michetti M; de Buys Roessingh AS; Raffoul W; She BR; Applegate LA Front Bioeng Biotechnol; 2020; 8():581. PubMed ID: 32637400 [TBL] [Abstract][Full Text] [Related]
5. Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology. Laurent A; Hirt-Burri N; Scaletta C; Michetti M; de Buys Roessingh AS; Raffoul W; Applegate LA Front Bioeng Biotechnol; 2020; 8():557758. PubMed ID: 33195124 [TBL] [Abstract][Full Text] [Related]
6. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control. Andriolo G; Provasi E; Brambilla A; Lo Cicero V; Soncin S; Barile L; Turchetto L; Radrizzani M Methods Mol Biol; 2021; 2286():131-166. PubMed ID: 33381854 [TBL] [Abstract][Full Text] [Related]
7. Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis. Ebrahimi-Barough S; Ai J; Payab M; Alavi-Moghadam S; Shokati A; Aghayan HR; Larijani B; Arjmand B Methods Mol Biol; 2021; 2286():199-212. PubMed ID: 32504294 [TBL] [Abstract][Full Text] [Related]
8. Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine. Laurent A; Abdel-Sayed P; Hirt-Burri N; Scaletta C; Michetti M; de Buys Roessingh A; Raffoul W; Applegate LA Cells; 2021 Sep; 10(10):. PubMed ID: 34685505 [TBL] [Abstract][Full Text] [Related]
9. Isolation, Culture, Cryopreservation, and Preparation of Skin-Derived Fibroblasts as a Final Cellular Product Under Good Manufacturing Practice-Compliant Conditions. Aydoğdu N; Öztel ON; Karaöz E Methods Mol Biol; 2021; 2286():85-94. PubMed ID: 33349903 [TBL] [Abstract][Full Text] [Related]
10. Optimized Manufacture of Lyophilized Dermal Fibroblasts for Next-Generation Off-the-Shelf Progenitor Biological Bandages in Topical Post-Burn Regenerative Medicine. Laurent A; Scaletta C; Abdel-Sayed P; Michetti M; Flahaut M; Simon JP; Roessingh AB; Raffoul W; Hirt-Burri N; Applegate LA Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440276 [TBL] [Abstract][Full Text] [Related]
11. Scalable Manufacturing of Human Hematopoietic Stem/Progenitor Cells Exploiting a Co-culture Platform with Mesenchymal Stromal Cells. Fernandes-Platzgummer A; Andrade PZ; Cabral JMS; da Silva CL Methods Mol Biol; 2021; 2286():107-120. PubMed ID: 32488668 [TBL] [Abstract][Full Text] [Related]
12. Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation. Laurent A; Abdel-Sayed P; Grognuz A; Scaletta C; Hirt-Burri N; Michetti M; de Buys Roessingh AS; Raffoul W; Kronen P; Nuss K; von Rechenberg B; Applegate LA; Darwiche SE Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33916829 [TBL] [Abstract][Full Text] [Related]
13. GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells. Aghayan HR; Payab M; Mohamadi-Jahani F; Aghayan SS; Larijani B; Arjmand B Methods Mol Biol; 2021; 2286():213-225. PubMed ID: 32504292 [TBL] [Abstract][Full Text] [Related]
14. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Ausubel LJ; Lopez PM; Couture LA Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873 [TBL] [Abstract][Full Text] [Related]
15. Autologous Platelet-Rich Plasma (CuteCell PRP) Safely Boosts Berndt S; Turzi A; Pittet-Cuénod B; Modarressi A Tissue Eng Part A; 2019 Nov; 25(21-22):1550-1563. PubMed ID: 30896295 [TBL] [Abstract][Full Text] [Related]
16. Human cord blood applications in cell therapy: looking back and look ahead. Zhou H; Chang S; Rao M Expert Opin Biol Ther; 2012 Aug; 12(8):1059-66. PubMed ID: 22681655 [TBL] [Abstract][Full Text] [Related]
17. Adipose tissue-derived extracellular fraction characterization: biological and clinical considerations in regenerative medicine. Bellei B; Migliano E; Tedesco M; Caputo S; Papaccio F; Lopez G; Picardo M Stem Cell Res Ther; 2018 Aug; 9(1):207. PubMed ID: 30092820 [TBL] [Abstract][Full Text] [Related]